Amgen Inc (BSP:AMGN34)
R$ 58.14 0 (0%) Market Cap: 881.03 Bil Enterprise Value: 1.20 Til PE Ratio: 34.15 PB Ratio: 19.04 GF Score: 86/100

Q1 2022 Amgen Inc Earnings Call Transcript

Apr 27, 2022 / 09:00PM GMT
Release Date Price: R$44.33 (-0.78%)
Operator

My name is RJ, and I will be your conference facilitator today for Amgen's First Quarter 2022 Financial Results Conference Call. (Operator Instructions) I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay, RJ. Thank you. Good afternoon, everybody, and welcome to our Q1 call. I think our performance in Q1 exemplifies our continued focus on execution while staying on track to deliver against our long-term objectives. So let's get started.

Slides have been posted. Quick reminder that we'll use non-GAAP financial measures in our presentation, and some of the statements will be forward-looking statements. Our SEC filings identify factors that could cause our actual results to vary or differ materially.

So with that, I would like to turn the call over to our Chairman and CEO, Bob Bradway. Bob?

Robert A. Bradway
Amgen Inc. - Chairman, CEO & President

Okay. Thank you, Arvind, and hello, everyone, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot